Aβ42 Mutants with Different Aggregation Profiles Induce Distinct Pathologies in Drosophila by Iijima, Koichi et al.
Ab42 Mutants with Different Aggregation Profiles Induce
Distinct Pathologies in Drosophila
Koichi Iijima
1,2,4*, Hsueh-Cheng Chiang
1,5, Stephen A. Hearn
1, Inessa Hakker
1, Anthony Gatt
2,
Christopher Shenton
3, Linda Granger
2,3, Amy Leung
1, Kanae Iijima-Ando
1,3,4, Yi Zhong
1*
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America, 2Laboratory of Neurodegenerative Diseases and Gene Discovery, Farber
Institute for Neurosciences, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America, 3Laboratory of Neurogenetics and Protein Misfolding
Diseases, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America, 4Department of Biochemistry and
Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America, 5Department of Neurobiology and Behavior, State University of
New York, Stony Brook, New York, United States of America
Abstract
Aggregation of the amyloid-b-42 (Ab42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer’s disease
(AD), and the prevention of Ab aggregation has been proposed as a therapeutic intervention in AD. However, recent reports
indicate that Ab can form several different prefibrillar and fibrillar aggregates and that each aggregate may confer different
pathogenic effects, suggesting that manipulation of Ab42 aggregation may not only quantitatively but also qualitatively
modify brain pathology. Here, we compare the pathogenicity of human Ab42 mutants with differing tendencies to
aggregate. We examined the aggregation-prone, EOFAD-related Arctic mutation (Ab42Arc) and an artificial mutation
(Ab42art) that is known to suppress aggregation and toxicity of Ab42 in vitro. In the Drosophila brain, Ab42Arc formed more
oligomers and deposits than did wild type Ab42, while Ab42art formed fewer oligomers and deposits. The severity of
locomotor dysfunction and premature death positively correlated with the aggregation tendencies of Ab peptides.
Surprisingly, however, Ab42art caused earlier onset of memory defects than Ab42. More remarkably, each Ab induced
qualitatively different pathologies. Ab42Arc caused greater neuron loss than did Ab42, while Ab42art flies showed the
strongest neurite degeneration. This pattern of degeneration coincides with the distribution of Thioflavin S-stained Ab
aggregates: Ab42Arc formed large deposits in the cell body, Ab42art accumulated preferentially in the neurites, while Ab42
accumulated in both locations. Our results demonstrate that manipulation of the aggregation propensity of Ab42 does not
simply change the level of toxicity, but can also result in qualitative shifts in the pathology induced in vivo.
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Introduction
The amyloid-b-42 (Ab42) peptide has been suggested to play a
central role in the pathogenesis of Alzheimer’s disease (AD), a
devastating, and currently incurable, neurodegenerative disorder
[1]. Aggregation of Ab42 peptide in the brain parenchyma is a
pathological hallmark of AD [2]. Genetic studies of early-onset
familial AD (EOFAD) provide a strong causative link between
Ab42 and AD [3], and some mutations in the Ab peptide promote
amyloid fibril formation [4,5]. These data suggest that Ab42
aggregation might be involved in AD pathogenesis [6], and Ab42
aggregation is therefore an attractive target for therapeutic
intervention in AD [7].
In vitro, the neurotoxicity of Ab42 has been often correlated with
the tendency of Ab42 to aggregate [8,9]. However, recent
evidence indicates that Ab42 can form a variety of misfolded
structures, including multiple monomer conformers, different
types of prefibrillar assemblies, and structurally distinct amyloid
fibrils, and that such structural polymorphisms may mediate the
diverse toxic effects of Ab42 [10–13]. These results suggest that
manipulation of Ab42 aggregation in vivo may not simply change
the magnitude of toxicity, but also qualitatively modify its
pathogenic effects.
We have previously shown that expression of the human Ab42
peptide in Drosophila brains induces age-dependent memory defects,
locomotor dysfunction, and neurodegeneration accompanied by
Ab42 deposits [14]. Using this model system, we investigated the
correlation between the aggregation tendencies of Ab42 and
memory defects, as well as neurodegeneration, through genetic
manipulation of Ab42 aggregation. We demonstrated that manip-
ulation of the aggregation propensity of Ab42 qualitatively as well as
quantitatively modified the pathogenicity of Ab42 in vivo.
Results and Discussion
The human Ab42 with the Arctic mutation (E22G substitution,
Ab42Arc) (Figure 1A), which causes early onset familial AD
(EOFAD) [4], is more aggregation-prone and toxic in vitro [5,15]
and accelerates the formation of amyloid deposits in the brains of
AD model mice [16,17]. In contrast, an artificial mutation, (L17P
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formation and toxicity in vitro [9,18] and prevents the formation
of amyloid deposits in C. elegans muscle [19].
A signal sequence was fused to the N-terminus of each Ab [14], to
target the peptide to the secretory pathway. Multiple transgenic lines
carrying a UAS-Ab42, UAS-Ab42Arc,o rUAS-Ab42art transgenewere
established. Expression of each Ab in the brain was driven by the
pan-neuronal elav-Gal4
c155 driver [20]. Since elav-Gal4 is on the X
chromosome, male progeny expressed more Ab peptide and
developed stronger phenotypes than female progeny due to dosage
compensation (data not shown). The results presented in this study
are from male flies, unless otherwise indicated.
Western blot analysis detected monomeric forms of Ab42,
Ab42Arc, and Ab42art as 4 kDa signals (Figure 1B). Monomeric
and oligomeric forms of Ab42art migrated slower than those of
Ab42 due to an amino acid substitution (Figure 1B and D).
Immunoprecipitation followed by mass spectrometry analysis
confirmed that the fused signal peptide was correctly cleaved, and
intact Ab42, Ab42Arc, and Ab42art peptides were produced (Figure
S1A–C). Immuno-electron microscopy (Immuno-EM) detected
Ab42 signals in the secretory pathway, including ER, Golgi, and
lysosomes (Figure 1C), with minimal signals in the mitochondria and
cytoplasm of neurons in the Kenyon cell region of Ab42 fly brains.
Ab42Arc and Ab42art peptides were also detected in the secretory
pathway (data not shown). Secretion of Ab peptides occurred in
Drosophila cultured cells (Figure S2), and, in Drosophila brains,
immuno-EM analysis occasionally detected Ab42 accumulation in
glial cells suggesting that Ab42 peptides were secreted from neurons
and then taken up by glial cells (Figure S3).
All Ab peptides caused late-onset locomotor defects and
premature death when expressed in neurons. Since the severity
of these phenotypes positively correlated with the expression level
of the peptides (Figure S4 and Table S1), we selected transgenic
lines with similar expression levels (Figure 1B, asterisks) to
characterize the accumulation profiles and the pathogenic effects
of each Ab peptide in the Drosophila brain.
To compare the ability of each Ab peptide to form small
oligomers, we quantified the levels of dimers (8 kDa), trimers
(12 kDa), and tetramers (16 kDa), as detected by Western blotting
(Figure 1D). This analysis revealed that Ab42Arc formed 2-fold
more dimers and trimers than did Ab42, while Ab42art formed
50% fewer dimers and tetramers. We also tested whether higher
molecular weight Ab oligomers were formed in fly brains with dot
blot analysis using A11 antibody [21]. We did not observe A11-
positive oligomers in any of Ab42Arc, Ab42 and Ab42art brain
lysates (Figure S5). During aging, Ab42 and Ab42Arc accumulat-
ed in the insoluble fraction of brain lysates (Figure 1E; extracted by
70% formic acid), with no significant accumulation in the soluble
fraction (Figure 1E; extracted by RIPA/1%SDS). Accumulation of
Ab42Arc in the insoluble fraction was more aggressive than that of
Figure 1. Expression, distribution, aggregation, and accumu-
lation profiles of mutant Ab42 peptides in fly brains. A,
Sequences of Ab42, Ab42Arc, and Ab42art. B, Expression levels of Ab
in independent transgenic lines (W; weak, M; moderate, S: strong
expression) at 1-2dae (top panel, Ab42), when accumulation of each Ab
in the insoluble fraction was minimum, were compared, and relative
ratios were shown below each lane and in Table S1 (n=3). Asterisks
r
indicate the fly lines primarily used in this study. elav-Gal4
c155 flies were
used as control. Tubulin was used as a loading control (bottom panel:
Tu). C, ImmunoEM detection of Ab42 in the endoplasmic reticulum (ER)
and Golgi, as well as a lysosome. Gold particles are absent in the control
(Control). N: nucleus, Scale bar: 1 mm. Neurons in Kenyon cell region of
Ab42 fly brains at 25dae were analyzed. D, Detection of dimers (di),
trimers (tri) and tetramers (tet) in fly brains. The level of each oligomer
was shown as a ratio relative to that of Ab42. Asterisks indicate
significant differences from Ab42 (n=3, P,0.05, Student’s t-test). E,
Age-dependent accumulation of Ab peptides in detergent-soluble and
insoluble fractions. The ages of the flies are indicated at the bottom.
doi:10.1371/journal.pone.0001703.g001
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eclosion (dae) flies). In contrast, Ab42art strongly accumulated in
the soluble fraction with greatly reduced accumulation in the
insoluble fraction (Figure 1E). It should be noted that although
age-dependent accumulation of Ab42Arc in FA fraction from 5 to
25dae was clearly observed, the level of Ab42Arc at 35dae was less
than that at 25dae, presumably due to a progressive cell loss in
Ab42Arc fly brains (See below). These results demonstrate that
Ab42Arc is consistently more, and Ab42art is significantly less,
prone to aggregate in vivo.
The severity of locomotor dysfunction and premature death
phenotypes of the transgenic flies correlated well with the
aggregation proneness of the Ab peptides. Climbing ability was
used to quantify locomotor activity [22]. Climbing disability in
80% of the flies occurred by 25, 35, and 45 dae in Ab42Arc, Ab42,
and Ab42art flies, respectively (Figure 2A). A similar tendency was
observed for the premature death phenotype. The average lifespan
of Ab42Arc flies (32.9 dae) was shorter than that of Ab42 flies
(46.2 dae), while Ab42art flies (51.4 dae) lived longer than Ab42
flies (Figure 2B).
However, the onset of memory defects measured by Pavlovian
olfactory classical conditioning [23] did not follow this simple
trend. This assay was conducted with younger flies (5 or 10 dae),
before the flies developed locomotor defects (Figure 2A). Data
obtained from male and female flies are presented separately, since
expression of Ab is higher in males than in females, as a result of
dosage compensation. For 5 dae flies in both male and female
groups, Ab42Arc flies showed the most severe 1 hour memory
defects (memory scores were measured 1 hour after the training
session), and Ab42art flies were also defective (Figure 2C). In
contrast, memory in Ab42 flies was indistinguishable from control
flies (Figure 2C). For 10 dae flies, all Ab flies reached a similar level
of memory defects in the male group (left panel in Figure 2D). In
the female group, memory scores remained the lowest in Ab42Arc
flies, and both Ab42art and Ab42 flies showed similar defects
(Figure 2D). A similar tendency was observed with the learning
assay (learning scores were obtained immediately after training)
(Figure S6). Of note, learning scores were normal in both 10 dae
Ab42 and Ab42art female flies, indicating that these flies were
specifically defective in short-term memory, the major clinical
manifestation observed in patients in the early stages of AD [24].
The sensory motor activity of the flies, including sensing odors and
electric shock, was indistinguishable from controls at 10 dae (Table
S2), indicating that the observed defects can be interpreted as
learning and memory defects.
Remarkably, Ab42, Ab42Arc, and Ab42art each induced
distinct pathologies. Neurodegeneration in the Ab fly brains was
observed as a vacuolar appearance both in the cell body and
neuropil regions. To quantify the area lost in these regions, we
focused on the mushroom body structure, in which the cell bodies
(Kenyon cell body), dendrites (Calyxes), and axon bundles (Lobes)
were easily identified [25]. Our analysis revealed that, at 25 dae,
Ab42Arc fly brains showed more extensive cell loss than that in
Ab42 or Ab42art brains (Figures 3A–F). However, the level of
neuropil degeneration was greatest in Ab42art flies (Figures 3A–F).
The enhanced neuropil degeneration observed in Ab42art flies
was further confirmed by confocal analysis. In this assay, each
Ab42 peptide was preferentially expressed in mushroom body
neurons using the OK107-gal4 driver, and the structure of
dendrites (Calyxes) and axons (Lobes) was visualized by co-
expressed CD8-GFP[26] (Figure 3G). Quantification of the size of
these structures revealed that Ab42art induced earlier onset and
more severe atrophy in both the dendrites (Calyxes) and axons
(Lobes) among all Ab flies (Figure 3G–I). The severity of the
Figure 2. Behavioral defects in Ab42, Ab42Arc, and Ab42art
flies. A, Locomotor dysfunction. The percent of flies at the top (yellow),
middle (magenta) or bottom (blue) of the vial at 10 seconds after
knocking flies to the bottom are shown (average6SEM (n=10)). B,
Premature death. The percent survivorship was plotted against the age
(dae). C and D, Memory defects. One hour memory was assessed by
Pavlovian olfactory conditioning at 5 dae (C) and 10 dae (D). Asterisks
indicate a significant difference from control (n=6 or 8, a,0.05, Tukey-
Kramer significant difference). Average memory scores6SEM are
shown.
doi:10.1371/journal.pone.0001703.g002
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were not due to differences in brain size (Figure S7).
Immunostaining and Thioflavin S (TS) staining, which labels
aggregated Ab42, revealed that the degenerated structures in
Ab42, Ab42Arc, and Ab42art flies were closely correlated with the
intraneuronal accumulation sites of each Ab peptide. Ab42Arc
accumulated primarily in the cell soma as large deposits (Figure 4E,
F, arrowheads in F), while Ab42art was distributed primarily in the
neurites (Figure 4G, H, arrows in H). Ab42 was detected both in
the cell body and in the neurites, but to a lesser extent than the
mutants (Figure 4C, D, arrowheads and arrows in D). Quantifi-
cation of TS-positive deposits and neurites in Ab fly brains is
shown in Figure 4K. These fly brains were negative for Congo-
Red staining (Figure S8), and no intraneuronal amyloid fibrils
were observed by electron microscopy, suggesting that the
majority of TS-positive aggregates did not contain amyloid fibril
structures. These distinct patterns of neurodegeneration and Ab
accumulation were confirmed in several independent transgenic
lines (data not shown).
This study highlights that the complex toxicities of Ab42 are
associated with different aggregation propensities in vivo. First, the
increase in Ab42 aggregation proneness associated with the
pathogenic Arctic mutation (E22G) correlated with more severe
detrimental effects on memory, locomotor ability, and lifespan
than those caused by Ab42 (Figure 2). These data are consistent
with the fact that Ab42Arc causes EOFAD [4], and indicates that
aggregation proneness contributes to Ab42 toxicity in vivo. Second,
an artificial mutation (L17P) that decreased Ab42 aggregation
proneness suppressed the toxicities toward locomotor function and
lifespan, but caused earlier onset of memory defects (Figure 2),
showing that not all pathogenic effects of Ab42 correlate directly
with aggregation proneness. Third, the differences in aggregation
Figure 3. Cell body and neuropil degeneration in Ab42, Ab42Arc, and Ab42art flies. A–E, Neurodegeneration in Ab flies at 25 dae. The cell
body and neuropil region in the mushroom body are enlarged. Arrowheads indicate neurodegeneration (C to E). F, Percentage of the area lost in the
cell body (green) and neuropil (magenta) regions are shown as averages6SEM (n=7–9 hemispheres). Asterisks indicate significant differences from
Ab42 (P,0.05, Student’s t-test). G, Atrophy of Calyxes (dendrites) and Lobes (axons) in Ab flies. H and I, Areas of Calyxes and Lobes were measured as
indicated in (G) and presented as averages6SEM (n=6 hemispheres). Asterisks indicate significant differences from control (P,0.05, Student’s t-test).
The ages of the flies are indicated at the bottom.
doi:10.1371/journal.pone.0001703.g003
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shifts in pathology in the fly brain, exemplified by distinct
neurodegeneration patterns accompanying the different accumula-
tion profiles of Ab42 peptides (Figure 3 and 4). Importantly, these
differences are not due to a difference in genetic background [27],
since these Ab flies were generated in the same genetic background.
Under physiological conditions, the Ab42 peptides are gener-
ated from amyloid precursor protein (APP) by b- and c-secretases
in the secretory pathway including, the transgolgi-network,
endosome-system, and plasma membrane [28]. Because Drosophila
has no or very low endogeneous b-secretase activity [29], we used
the artificial expression system to achieve high expression levels of
Ab42 in fly brains. In our transgenic flies, Ab42 peptides were
expressed in the ER and distributed to the late secretory pathway
compartments, axons, dendrites, and presynaptic terminals, as well
as secreted from neurons (Figure 1C, S2 and S3). Although the ER
is not a major cellular site for Ab generation under physiological
conditions [28], several lines of evidence suggest that, under
abnormal conditions, Ab may be generated, retained, or recycled
back to the ER and may induce ER stress [30–35]. Our fly models
may recapitulate neuronal dysfunction and degeneration induced
by such abnormal intracellular metabolisms of Ab42. It would be
also important to examine the effects of the Arctic (E22G) and
artificial (L17P) mutations on intracellular distribution and
toxicities of Ab42 generated from the full-length APP.
In summary, our results lead us to predict two issues. First, the
partial prevention of Ab42 amyloidgenesis by aggregation
inhibitors may result in qualitative shifts in the pathogenic effects
of Ab42. Second, the tendency of Ab42, a natively unfolded
polypeptide consist primarily of random-coil structure in their
native and soluble states [36,37], to aggregate may be affected by a
combination of genetic [38], environmental [39], and aging factors
[40], and the resultant Ab42 conformers or species may contribute
to the heterogeneous pathogenesis of AD [41]. The existence of
different ‘‘Ab species’’ has been recently verified both in vitro [12]
and in vivo [42].
Materials and Methods
Drosophila genetics and stocks
cDNA fragments encoding the human Ab42, Ab42Arc, and
Ab42art peptides were amplified by PCR from human APP
cDNA, fused to the rat pre-proenkephalin signal peptide, cloned
into the pUAST Drosophila transformation vector and microinject-
ed into fly embryos of the w
1118 (isoCJ1) genotype. Several
transgenic lines for each Ab construct were established. The flies
were raised and maintained at 25uC, under conditions of 70%
humidity and a 12 h:12 h light:dark cycle. The transgenic UAS-
CD8::GFP;;OK107 line was a kind gift from Dr. L. Luo [26]. UAS-
nlsGFP and elav-GAL4
c155 flies were obtained from the Blooming-
ton Drosophila Stock Center. For Pavlovian olfactory conditioning,
the elav-GAL4
c155 line was outcrossed with w
1118 (isoCJ1) flies, an
isogenic line, for 5 generations. Genotypes of flies used in this
study are as follows: Control; elav-GAL4
c155/Y,A b42; elav-
GAL4
c155/Y;; UAS-Ab42/+,A b42Arc; elav-GAL4
c155/Y;; UAS-
Ab42Arc/+ and Ab42art; elav-GAL4
c155/Y;; UAS-Ab42art/+.I n
figure 3G, H and I, flies’ genotypes are as follows: Control; w/
Y;UAS-CD8::GFP/+;;OK107/+,A b42; w/Y; UAS-CD8::GFP/
+;UAS-Ab42/+;OK107/+,A b42Arc; w/Y; UAS-CD8::GFP/
+;UAS-Ab42Arc/+;OK107/+ and Ab42art; w/Y; UAS-CD8::GFP/
+;UAS-Ab42art/+;OK107/+.
Western blot and dot blot analysis
For sequential extractions, fly heads were homogenized in RIPA
buffer (50 mM Tris-HCl, pH 8.0, 0.5% sodium deoxycholate, 1%
Triton X-100, 150 mM NaCl) containing 1% SDS. Lysates were
centrifuged at 100,000 g for 1h, and supernatants were collected
(SDS-soluble fraction). SDS-insoluble pellets were further homoge-
nized in 70% formic acid (Sigma) followed by centrifugation at
13,000 rpm for 20 min and the supernatants were collected (FA
fraction).FormicacidwasevaporatedbySpeedVac(Savant,SC100)
and protein was resuspended in dimethyl sulfoxiside (Sigma).
Protein extracts were immunoprecipitated with the anti-Ab
antibody 6E10 (Signet), separated on 10–20% Tris-Tricine gels
(Invitrogen), and transferred to nitrocellulose membranes (Invitro-
gen). The membranes were boiled in phosphate buffered saline
(PBS) for 3 min, blocked with 5% non-fat dry milk (Nestle ´) and
Figure 4. Distribution and aggregation of Ab42, Ab42Arc, and
Ab42art peptides in fly brains. A,C,E,G and I, Immunostaining of
brains of 25 dae flies with anti-Ab antibody (green). In (A), nuclei were
stained with propidium iodide (magenta). B,D,F,H and J, Thioflavin S
(TS) staining of brains of 25 dae flies. Arrowheads and arrows indicate
TS-positive deposits and neurites, respectively. No signal was detected
in the control (I, J). Scale bar in J: 50 mm. (C) and (D) are enlarged
images of the boxed regions in (A) and (B), respectively. K, Numbers of
TS-positive deposits and neurites were presented as averages6SD
(n=6 hemispheres). Asterisks indicate significant differences from Ab42
(P,0.05, Student’s t-test).
doi:10.1371/journal.pone.0001703.g004
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To quantify levels of expression of the Ab peptide, heads from 1–2
dae flies were homogenized in Tris-Tricine sample buffer
(Invitrogen), centrifuged at 13,000 rpm for 20 min and the
supernatants were subjected to Western blotting, as described
above. The signal intensity was quantified using ImageJ (NIH).
For dot blot analysis, fly heads were homogenized in 2% SDS
followed by centrifugation at 13,000 rpm for 10 min. The
supernatants were applied to a nitrocellulose membrane and air-
dried. The membranes were blocked with 5% non-fat dry milk
(Nestle ´) and blotted with the A11 (Invitrogen) or 6E10 antibodies
(Signet).
Immunoprecipitation and mass spectrometric analysis
Two hundred Ab fly heads were homogenized in 70% formic
acid (Sigma) followed by centrifugation at 13,000 rpm for 20 min.
The supernatant was evaporated using a Speed Vac (Savant,
SC100) and protein was resuspended in dimethyl sulfoxiside
(Sigma). The Ab peptides were immunoprecipitated with the 6E10
antibody (Signet) and Protein-G Sepharose beads. The beads were
washed three times with washing buffer (140 mM NaCl, 10 mM
Tris-HCl, pH 8.0) containing 0.1% Octyl b-D-glucopyranoside,
and the peptides were eluted with 70% formic acid and subjected
to MALDI-TOF mass spectrometry.
Climbing assay
Approximately 25 flies were placed in an empty plastic vial. The
vial was gently tapped to knock the flies to the bottom and the
number of flies at the top, middle, or bottom of the vial was scored
after 10 seconds under red light (Kodak, GBX-2, Safelight Filter).
Experiments were repeated more than three times, and a
representative result was shown.
Survival assay
Food vials containing 25 flies were placed on their sides at 25uC,
under conditions of 70% humidity and a 12 h:12 h light:dark
cycle. Food vials were changed every 2–3 days, and the number of
dead flies was counted each time. At least four vials for each
genotype were prepared. Experiments were repeated more than
three times, and a representative result was shown.
Pavlovian olfactory associative learning
Approximately 100 flies were trained by exposure to electro-
shock paired with one odour [octanol (OCT, 10
23(v/v)) or
methylcyclohexanol (MCH, 10
23(v/v))] for 60 s and subsequent
exposure to the other odour without electroshock for 60 s [23].
Immediately after training, learning was measured by allowing
flies to choose between the two odours for 120 s. For one hour
memory, trained flies were transferred to food vials, which were
placed on their side in the dark at 25uC and 70% humidity, and
tested after one hour. The performance index (PI) was calculated
by subtracting the number of flies making the incorrect choice
from those making the correct one, dividing by the total number of
flies, and multiplying by 100. Absolute odour avoidance was
quantified by a T-maze with one of the two odours (octanol [10
3
(vol/vol)] or methylcyclohexanol [10
3 (vol/vol)]) coming from one
side and air from the other side. Naı ¨ve flies avoid odours, and the
performance index was calculated by subtracting the number of
flies that chose the odour side of the T-maze from those in the air
side, dividing by the total number of flies and multiplying by 100.
Electric shock reactivity was tested by putting approximately 100
flies in a T-maze having one arm with electric shock and one arm
without electric shock. The performance index was calculated by
subtracting the number of flies that chose the electric shock arm of
the T-maze from those in the arm without shock, dividing by the
total number of flies and multiplying by 100.
Quantification of neurodegeneration
Heads were fixed in 4% paraformaldehyde (Electron Micros-
copy Sciences), processed to embed in paraffin blocks, and
sectioned at a thickness of 6 mm. Sections were placed on slides,
stained with haematoxylin and eosin (Vector), and examined by
bright-field microscopy. To quantify neurodegeneration in the cell
body and neuropil of the mushroom body structures, images of the
sections which included the Kenyon cell body and/or Calyx were
captured, and the area of the vacuoles in the Kenyon cell body or
Calyx region was measured in each image. The ratio was calculated
by dividing the sum of the vacuole areas by the total area of the
Kenyon cell body or Calyx region. Seven to nine hemispheres from
fiveflieswereanalyzedforeachgenotype.Toquantifytheatrophyof
dendritic and axonal structures of the mushroom body neurons, the
GFP signal in whole fly brains carrying UAS-CD8::GFP;;OK107 was
analyzed using confocal microscopy (Carl Zeiss LSM 510). The area
of Calyxes (dendritic structures of the Kenyon cells), Lobes (axon
bundles of the Kenyon cells) and the size of the brains was measured
using LSM Image software. Six hemispheres from three flies were
quantified for each genotype.
Whole-mount immunostaining and Thioflavin S staining
Fly brains were dissected in cold PBS and fixed in PBS
containing 4% paraformaldehyde (EMS), and then placed under
vacuum in PBS containing 4% paraformaldehyde and 0.25%
Triton X-100. After permeabilization with PBS containing 2%
TritonX-100,thebrains were treated with 70%formicacid(Sigma),
and stained with a mouse monoclonal anti-Ab antibody (Chemicon)
followed by detection with biotin-XX goat anti-mouse IgG and
streptavidin-Oregon Green 488 conjugate (Molecular Probes).
Nuclei were counterstained with propidium iodide (Molecular
Probes). To detect nuclei of glial cells, fly heads were stained with
an anti-Repo antibody (DSHB) followed by detection with Texas
Red goat anti-mouse IgG (Molecular Probes). The brains were
analyzed using a confocal microscope (Carl Zeiss LSM 510). For
Thioflavin S (TS) staining, the brains were permeabilized and
incubated in 50% EtOH containing 0.1% TS (Sigma) overnight.
After washing in 50% EtOH and PBS, the brains were analyzed
using a confocal microscope. TS-positive deposits and neurites were
quantified from six hemispheres from three flies per genotype.
Congo-Red staining
Heads were fixed in 4% paraformaldehyde, processed to embed
in paraffin blocks, and sectioned at a thickness of 10 mm. Sections
were placed on slides and stained with an amyloid stain, Congo
Red kit (Sigma), following the manufacuturer’s protocol. Apple-
green birefringence was examined by bright-field microscopy with
a polarizing filter (Leica). Slides of human kidney tissue containing
intracellular amyloid (Sigma) were processed at the same time as
positive controls.
Immuno-gold labelling and electron microscopy
Probosces were removed from decapitated heads, which were
then immersion-fixed overnight in 4% glutaraldehyde and 2%
paraformaldehyde in 0.1 M PBS. Samples were post-fixed 1 h in
ferrocyanide-reduced osmium tetroxide (1% osmium tetroxide and
1.5% potassium ferrocyanide). Fixation was followed by dehydra-
tion in a graded alcohol series and infiltration with LR White resin
(2 h in 50% LR White in ethanol and 24 h in 100% LR White)
Complex Pathogenicity of Ab42
PLoS ONE | www.plosone.org 6 February 2008 | Volume 3 | Issue 2 | e1703using constant rotation. After transferring the samples to gelatin
capsules with fresh LR White resin, the samples were polymerized
overnight at 60uC. Thin sections (100 nm) of Kenyon cells and
neuropil regions of the mushroom body were collected on nickel
grids (100 mesh, Veco-EMS). For immunogold labelling of Ab42
transgenic and control fly heads, thin sections were first incubated
for 2 minutes in 10% hydrogen peroxide for antigen retrieval, jet-
rinsed in distilled water, and then placed on drops of 1%
deacetylated BSA in PBS for 5 min. The grids were then transferred
to drops of a rabbit antibody specific for human Ab42 (Chemicon-
Millipore) diluted 1:10 in PBS and incubated for 2 h at room
temperature. Unbound primary antibody was removed by rinsing
the grids through 5 drops of PBS. Antibody was detected by
incubating grids for 1 h in 10 nm colloidal gold conjugated goat
anti-rabbit H&L (GE Healthcare) diluted 1:10 in PBS. Grids were
then rinsed in 10 drops of distilled water and air-dried. Thin sections
were counterstained for 5 minutes in 3% uranyl acetate dissolved in
30% ethanol and then rinsed in distilled water.
Drosophila S2 cell culture
Drosophila Schneider’s cells (S2 cells) were maintained in
Schneider’s Drosophila Medium (Gibco) supplemented with 10%
FBS (GEMINI) and an Antibiotic-Antimycotic mixture (Gibco).
The cells were transiently transfected with Actin-Gal4 and UAS-Ab
plasmid constructs using a calcium phosphate transfection kit
(Invitrogen). Culture medium was replaced at 12 h post-transfec-
tion, and cells were cultured for an additional 24 h. The cells and
culture medium were then harvested and subjected to immuno-
precipitation followed by Western blot analysis as described above.
Supporting Information
Figure S1 MS/IP analysis of Ab peptides expressed in fly brains.
Each Ab peptide was immunoprecipitated using the anti-Ab
antibody and subjected to MALDI-TOF mass spectrometry. Ab42
(A), Ab42Arc (B), and Ab42art (C) were each detected at their
predicted mass.
Found at: doi:10.1371/journal.pone.0001703.s001 (0.98 MB PDF)
Figure S2 Secretion of Ab peptides expressed in Drosophila S2
cells. The levels of Ab42 (blue), Ab42Arc (magenta), and Ab42art
(green) in the culture medium were detected by Western blotting,
normalized to intracellular Ab levels, and shown as a ratio relative
to that of Ab42. Each Ab peptide was secreted at different levels.
Asterisks indicate a significant difference from Ab42 (n=3,
P,0.05, Student’s t-test).
Found at: doi:10.1371/journal.pone.0001703.s002 (0.08 MB PDF)
Figure S3 Glial cells accumulate Ab42 peptide produced in
neurons in the Drosophila brain. ImmunoEM analysis detected
Ab42 (gold particles, arrowhead) in glial cells in brains of 25 dae
flies with Ab42 expression driven by elav-Gal4c155 (D). Scale bar
in D: 1 mm. Confocal analysis revealed that elav-Gal4c155 does
not drive the expression of transgene in glial cells. All nuclei of
neurons in the fly brain were labeled by GFP fused to a nuclear
localization signal driven by elav-Gal4c155 (A, green). The brain
was counterstained with anti-Repo, a marker for Drosophila glial
cells (B, magenta). The overlay image showed no significant
overlap between the two signals (C). Scale bar in A, 50 mm.
Found at: doi:10.1371/journal.pone.0001703.s003 (3.82 MB PDF)
Figure S4 Behavioral defects induced by the expression of
Ab42, Ab42Arc, and Ab42art peptides were dose dependent. A, C
and E, Locomotor dysfunction in independent transgenic lines (W;
weak, M; moderate, S; strong expression) of Ab42 (A), Ab42Arc
(C), and Ab42art (E). The percent of flies at the top (yellow),
middle (magenta), or bottom (blue) of the vial at 10 seconds after
knocking flies to the bottom are shown (average6SEM (n=10)).
B, D and F, The percent survivorship of independent transgenic
lines (W, M, and S) of Ab42 (B), Ab42Arc (D), and Ab42art (F) was
plotted against the age (dae). The expression levels of Ab peptides
in all transgenic lines are shown in Figure 1B, and indicated as S
(strong), M (moderate) or W (weak). The results are summarized in
table S1. In the main text, the data from Ab42 M, Ab42Arc M
and Ab42art M (asterisks in Figure 1B) are presented.
Found at: doi:10.1371/journal.pone.0001703.s004 (0.40 MB PDF)
Figure S5 No A11-positive Ab oligomers in Ab42, Ab42Arc, and
Ab42art fly brains. Fly brain lysates (1 or 2 ml) were applied on
membrane and probed with 6E10 (top) or oligomer-specific antibody,
A11 (bottom). No specific signal was observed with A11 antibody
(top, compare Control and Ab42Arc, Ab42 or Ab42art), while 6E10
detected Ab in fly brains (bottom, compare Control and Ab42Arc,
Ab42 or Ab42art). elav-Gal4c155 flies were used as control.
Found at: doi:10.1371/journal.pone.0001703.s005 (1.61 MB PDF)
Figure S6 Learning defects in Ab42, Ab42Arc, and Ab42art
flies. Learning ability was assessed by Pavlovian olfactory
conditioning at 10 dae. Asterisks indicate a significant difference
from control (n=6–8, a,0.05, Tukey-Kramer significant differ-
ence). Average learning scores6SEM are shown.
Found at: doi:10.1371/journal.pone.0001703.s006 (0.04 MB PDF)
Figure S7 Brain sizes of control, Ab42, Ab42Arc, and Ab42art
flies were not significantly different. The thickness of fly brains was
measured as indicated, and presented as average6SEM (n=5
individual flies). The age of the flies is indicated at the bottom.
Found at: doi:10.1371/journal.pone.0001703.s007 (0.62 MB PDF)
Figure S8 The majority of Ab aggregates in fly brains are not
stained by Congo-Red. Paraffin sections of brains of 25 dae
control (B), Ab42 (C), Ab42Arc (D) and Ab42art (E) flies were
stained with Congo-Red. Sections from human kidney tissue
containing intracellular amyloid were used as a positive control
(A). Amyloid was observed as pink signals under bright field, and
b-pleated structures were detected as birefringent apple-green
signals using a polarizing filter (arrows in (A)). None of Ab fly
brains were stained with Congo-Red (C–E). The numerous
vacuoles in (C–E) indicate neurodegeneration. For this analysis,
transgenic lines with the highest expression of each Ab peptide
(Ab42 S, Ab42Arc M and Ab42art S) were used.
Found at: doi:10.1371/journal.pone.0001703.s008 (7.67 MB PDF)
Table S1 Summary of the characterization of Ab transgenic
lines. Asterisks (*) indicate transgenic lines primarily used in this
study.
Found at: doi:10.1371/journal.pone.0001703.s009 (0.08 MB PDF)
Table S2 Shock reactivity and olfactory acuity of transgenic flies
at 10 dae. Ab42, Ab42Arc, and Ab42art flies did not show any
significant differences from control flies (n=6, a,0.05, Tukey-
Kramer significant difference). Average scores6SEM are shown.
In MCH olfactory acuity of males, there were no differences
relative to controls, but Ab42Arc and Ab42art flies were
significantly different from each other (*).
Found at: doi:10.1371/journal.pone.0001703.s010 (0.18 MB PDF)
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